Abstract
Two systems are known to transfer electrons in hepatic microsomes: 1) the NADPH-dependent cytochrome P-450 monooxygenase system, and 2) the NADH dependent cytochrome b5 system. Their coexistence in the same organelle suggested to Estabrook and associates (Estabrook et al., 1971; Hildebrandt and Estabrook, 1971) that the systems might interact during the oxidation of drug substrates in much the same way electron transfer systems interact in mitochrondria. As evidence for the interaction of the two systems, they showed that the rate of NADH oxidation by liver microsomes was enhanced in the presence of NADPH and drug substrate, and that the rate of oxidation of NADH was related to the rate of oxidation of the substrate. They further implicated cytochrome b5 in cytochrome P-450 monooxygenase reactions by showing that the steady state of reduced cytochrome b5 in the presence of NADPH and NADH was decreased by the addition of drug substrate. Other experiments eliminated some alternative possibilities that might explain these observations, e.g., the possibility that NADH was converted to NADPH, or that NADH was sparing NADPH used in competing reactions occurring simultaneously in microsomes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Björkhem, I. and Danielsson, H. 1973. Heterogeneity of hepatic mixed function oxidases. Biochem. Biophys. Res. Comm. 51: 766–774.
Buening, M. and Franklin, M. 1974. Limitations in the use of the 340 nm absorbance maximum of NADPH for the determination of oxidation rates and stoichiometry during rat hepatic microsomal metabolism. Mol. Pharmacol, in press.
Chaplin, M. D. and Mannering, G. J. 1970. Role of phospholipids in the hepatic microsomal drug metabolizing system. Mol. Pharmacol. 6: 631–640.
Cinti, D. L. and Ozols, J. 1975. The role of cytochrome b5 in mixed function oxidations: effect of microsomal binding of the hemoprotein on hepatic N-demethylations. This publication.
Cinti, D. L., Moldeus, P. and Schenkman, J. B. 1972. The role of the mitochondria in rat liver mixed function oxidation reactions. Biochem. Biophys. Res. Comm. 47: 1028–1035.
Cohen, B. S. and Estabrook, R. W. 1971. Microsomal electron transport reactions. II. The use of reduced triphospho-pyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrates. Arch. Biochem. Biophys. 143: 46–53.
Cohen, G. M. and Mannering, G. J. 1974. Sex-dependent differences in drug metabolism in the rat. III. Temporal changes in Type I binding and NADPH-cytochrome P-450 reductase during sexual maturation. Drug Metab. Disp. 2: 285–292.
Conney, A. H. 1967. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317–366.
Conney, A. H., Brown, R. R., Miller, J. A. and Miller, E. C. 1957. The metabolism of methylated aminoazo dyes. VI. Intracellular distribution and properties of the demethylase system. Cancer Res. 17: 628–633.
Coon, M. J., van der Hoeven, T. A., Haugen, D. A., Guengerich, F. P., Vermilion, J. L. and Bailou, D. P. 1975. Biochemical characterization of highly purified cytochrome P-450 and other components of the mixed function oxidase system of liver microsomal membranes. This volume, p. 26.
Correia, M. A. and Mannering, G. J. 1973a. DPNH synergism of TPNH-dependent mixed function oxidase reactions. Drug Metab. Disp. 1: 139–149.
Correia, M. A. and Mannering, G. J. 1973b. Reduced diphospho-pyridine nucleotide synergism of the reduced triphospho-pyridine. I. Effects of activation and inhibition of the fatty acyl coenzyme A desaturation. Mol. Pharmacol. 9: 455–469.
Correia, M. A. and Mannering, G. J. 1973c. Reduced diphospho-pyridine nucleotide synergism of the reduced triphospho-pyridine. II. Role of Type I drug-binding site of cytochrome P-450. Mol. Pharmacol. 9: 470–485.
Enomoto, K. and Sato, R. 1973. Incorporation in vitro of purified cytochrome b2 into liver microsomal membranes. Biochem. Biophys. Res. Comm. 51: 1–7.
Estabrook, R. W., Shigematsu, A. and Schenkman, J. B. 1970. The contribution of the microsomal electron transport pathway to the oxidative metabolism of liver. Adv. Enzyme Reg. 8: 121–130.
Estabrook, R. W., Franklin, M., Baron, J., Shigematsu, A. and Hildebrandt, A. 1971. Properties of the membrane-bound electron transfer complex of the hepatic endoplasmic reticulum associated with drug metabolism. IN E. Mihich, Ed., Drugs and Cell Regulation, 227–257.
Gigon, P. L., Gram, T. E. and Gillette, J. R. 1968. Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH. Biochem. Biophys. Res. Comm. 31: 558–562.
Gigon, P. L., Gram, T. E. and Gillette, J. R. 1969. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates. Mol. Pharmacol. 5: 109–122.
Gillette, J. R. 1966. Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. Advan. Pharmacol. 4: 219–261.
Gillette, J. R. 1971. Factors affecting drug metabolism. Ann. N. Y. Acad. Sci. 179: 43–66.
Hildebrandt, A. and Estabrook, R. W. 1971. Evidence for the participation of cytochrome b5 in hepatic microsomal mixed function oxidation reactions. Arch. Biochem. Biophys. 143: 66–79.
Holtzman, J. L. 1970. Effect of 4,4-dideuteration of reduced nicotinamide adenine dinucleotide phosphate on the mixed function oxidases of hepatic microsomes. Biochemistry 9: 995–1001.
Holtzman, J. L. and Carr, M. L. 1970. Inhibition of hepatic microsomal mixed function oxidases by D2O. Life Sci. 9: 1033–1038.
Holtzman, J. L. and Rumack, B. H. 1971. The kinetics of cytochrome P-450 reductase stimulation by ethylmorphine. Life Sci. 10: 669–677.
Hrycay, E. G. and Estabrook, R. W. 1974. The effect of extra bound cytochrome b5 on cytochrome P-450-dependent enzyme activities in liver microsomes. Biochem. Biophys. Res. Comm. 60: 771–778.
Imai, Y. and Omura, T. 1974. Unpublished results cited by Mannering, Kuwahara and Omura (Biochem. Biophys. Res. Comm. 57:476–481).
Imai, Y. and Sato, R. 1966. Substrate interaction with hydroxylase system in liver microsomes. Biochem. Biophys. Res. Comm. 22: 620–626.
Jansson, I. and Schenkman, J. B. 1973. Evidence against participation of cytochrome b5 in the hepatic microsomal mixed-function oxidase reaction. Mol. Pharmacol. 9: 840–845.
Jeffery, E. and Mannering, G. J. 1974a. Discrepancy in the measurement of TPNH oxidized during N-demethylation due to the presence of nucleotide pyrophosphatase. Mol. Pharmacol, in press.
Jeffery, E. and Mannering, G. J. 1974b. Unpublished results.
Lichtenberger, F. 1975. Discussion in this publication.
Lu, A. Y. H. 1974. Private communication.
Lu, A. Y. H., West, S. B., Vore, M., Ryan, D. and Levin, W. 1974. Role of cytochrome b5 in hydroxylation by a reconstituted cytochrome P-450-containing system. J. Biol. Chem. 249, in press.
Lu, A. Y. H., Levin, W., West, S. B., Vore, M., Ryan, D. Kuntzman, and Conney, A. H. 1975. Role of cytochrome b5 in NADPH-and NADH-dependent hydroxylation by the reconstituted cytochrome P-450- or P-448-containing system. This publication.
Mannering, G. J. 1968. Significance of stimulation and inhibition of drug metabolism in pharmacological testing. In A. Burger, Ed. Selected Pharmacological Testing Methods, 51–119.
Mannering, G. J. 1971a. Role of substrate binding to P-450 hemoprotein in drug metabolism. IN E. Mihich, Ed., Drugs and Cell Regulation, 197–225.
Mannering, G. J. 1971b. Properties of cytochrome P-450 as affected by environmental factors: qualitative changes due to administration of polycyclic hydrocarbons. Metabolism 20: 228–245.
Mannering, G. J. 1971c. Microsomal enzyme systems which catalyze drug metabolism. IN B. N. LaDu, H. G. Mandel and E. L. Way, Eds. Fundamentals of Drug Metabolism and Drug Disposition, 206–252.
Mannering, G. J., Kuwahara, S. and Omura, T. 1974. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADH-dependent mono-oxidase system of hepatic microsomes. Biochem. Biophys. Res. Comm. 57: 476–481.
Modurzadeh, J. and Kamin, H. 1965. Reduction of microsomal cytochromes by pyridine nucleotides. Biochem. Biophys. Acta. 99: 205–226.
Netter, K. J. and Illing, H. P. A. 1974. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation. Xenobiotica 4: 549–561.
Nelson, D. and Mannering, G. J. 1974. Unpublished results.
Oshino, N. 1972. Dynamic behavior during dietary induction of the terminal enzyme (cyanide-sensitive factor) of the stearyl CoA desaturation system of rat liver microsomes. Arch. Biochem. Biophys. 149: 378–387.
Oshino, N., Imai, Y. and Sato, R. 1971. A function of cytochrome b5 in fatty acid desaturation by rat liver microsomes. J. Biochem. 69: 155–168.
Oshino, N. and Sato, R. 1971. Stimulation by phenols of the re-oxidation of microsomal bound cytochrome b5 and its implication to fatty acid desaturation. J. Biochem. 69: 169–180.
Oshino, N. and Sato, R. 1972. Dietary control of the microsomal stearyl CoA desaturation enzyme system in rat liver. Arch.Biochem. Biophys. 149: 369–377.
Sasame, H. A., Mitchell, J. R., Thorgeirsson, S. and Gillette, J. R. 1973. Relationship between NADH and NADPH oxidation during drug metabolism. Drug Metab. Disp. 1: 150–155.
Sasame, H. A., Thorgeirsson, S. S., Mitchell, J. R. and Gillette, J. R. 1974a. The possible involvement of cytochrome b5 in the oxidation of lauric acid by microsomes from kidney cortex and liver of rats. Life Sci. 14: 35–46.
Sasame, H. A., Thorgeirsson, S. S., Menard, R. H., Hinson, J. A., Mitchell, J. R., and Gillette, J. R. 1974b. A role of cytochrome b5 in both NADH and NADPH-mediated cytochrome P-450 enzymatic reaction in mammalian tissues. Fed. Proc. 33: 1437.
Sasame, H. A., Thorgeirsson, S. S., Mitchell, J. R. and Gillette, J. R. 1975. The role of cytochrome b5 in cytochrome P-450 enzymes. This publication.
Schenkman, J. B. 1968. Effect of substrates on hepatic microsomal cytochrome P-450. Hoppe-Seyler’s Z. Physiol. Chem. 349: 1624–1628.
Schenkman, J. B. and Jansson, I. 1975. Interaction between microsomal electron transfer pathways. This publication.
Schenkman, J. B., Frey, I., Remmer, H. and Estabrook, R. W. 1967. Sex differences in drug metabolism by rat liver microsomes. Mol. Pharmacol. 3: 516–525.
Shoeman, D. W., Chaplin, M. D. and Mannering, G. J. 1969. Induction of drug metabolism. III. Further evidence for the formation of a new P-450 hemoprotein after treatment of rats with 3-methylcholanthrene. Mol. Pharmacol. 5: 412–419.
Sitar, D. S. and Mannering, G. J. 1973. Determination of apparent kinetic constants of the microsomal hydroxylation of amo-barbital, hexobarbital and pentobarbital. Drug Metab. Disp. 1: 663–668.
Strittmatter, P., Rogers, M. J. and Spatz, L. 1972. The binding of cytochrome b5 to liver microsomes. J. Biol. Chem. 247: 7188–7194.
Staudt, H., Lichtenberger, F. and Ullrich, V. 1974. The role of NADH in uncoupled microsomal monoxygenations. Eur. J. Biochem. 46: 99–106.
van der Hoeven, T. A., Haugen, D. A., and Coon, M. J. 1974. Cytochrome P-450 purified to apparent homogeneity from phenobar-bital-induced rabbit liver microsomes: catalytic activity and other properties. Biochem. Biophys. Res. Comm. 60: 569–575.
West, S. B., Levin, W., Ryan, D., Vore, M. and Lu, A. Y. H. 1974. Liver microsomal electron transport systems. II. The involvement of cytochrome b5 in the NADH-dependent hydroxylation of 3,4-benzpyrene by a reconstituted cytochrome P-448-containing system. Biochem. Biophys. Res. Comm. 58: 516–522.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Mannering, G.J. (1975). Role of Cytochrome b5 in the NADH Synergism of NADPH-Dependent Reactions of the Cytochrome P-450 Monooxygenase System of Hepatic Microsomes. In: Cooper, D.Y., Rosenthal, O., Snyder, R., Witmer, C. (eds) Cytochromes P-450 and b5 . Advances in Experimental Medicine and Biology, vol 58. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9026-2_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9026-2_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9028-6
Online ISBN: 978-1-4615-9026-2
eBook Packages: Springer Book Archive